Literature DB >> 19908144

Adsorptive depletion of alpha4 integrin(hi)- and CX3CR1hi-expressing proinflammatory monocytes in patients with ulcerative colitis.

Shin-ichiro Takeda1, Toru Sato, Tatsuro Katsuno, Tomoo Nakagawa, Yoshiko Noguchi, Osamu Yokosuka, Yasushi Saito.   

Abstract

BACKGROUND: Two main functionally distinct monocytes phenotypes are known: the CD14(hi)CD16(-) "classical" and the CD14(+)CD16(+) "proinflammatory" phenotypes. The latter phenotype is elevated in patients with ulcerative colitis (UC) and is suspected to have a major role in the immunopathogenesis of UC. AIM: To selectively deplete circulating proinflammatory CD14(+)CD16(+) monocyte phenotype.
METHODS: Seven corticosteroid-naïve patients with UC (clinical activity index = 8.7 +/- 1.3) and seven healthy subjects were included. In patients with UC, granulocyte/monocyte adsorption (GMA) was done with an Adacolumn that selectively adsorbs leucocytes of the myeloid lineage. Blood from all subjects at baseline and from the patients immediately after the first GMA session was processed. Isolated monocytes were subjected to fluorescence-activated cell sorter analyses.
RESULTS: The seven UC patients achieved remission (CAI <or=4) after 5-10 GMA sessions. GMA induced a strong fall in the ratio (%) of CD14(+)CD16(+) to CD14(hi)CD16(-) monocytes, from 10.0 +/- 1.4 to 3.0 +/- 0.9. Further, expressions of alpha4 integrin (374.8 +/- 26.1 mean fluorescence intensity, MFI) and CX(3)CR1 (49.5 +/- 4.6 MFI) were significantly high on CD14(+)CD16(+)monocytes as compared with on CD14(hi)CD16(-) monocytes (169.2 +/- 17.2 and 33.2 +/- 3.6 MFI, respectively). Additionally, GMA significantly increased the ratio of the CD14(hi)CD16(-)CCR2(low) "immature" monocytes from 3.74 +/- 0.62 to 8.11 +/- 0.56 MFI.
CONCLUSIONS: We found high expressions of alpha4 integrin and CX(3)CR1 on monocytes in patients with active UC, known to promote the extravasation of CD14(+)CD16(+) monocytes into the mucosa. GMA effectively depletes CD14(+)CD16(+) monocytes and concomitantly increases CD14(hi)CD16(-)CCR2(low) "immature" monocytes; thus GMA was associated with the emergence of less inflammatory monocyte phenotype in circulation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19908144     DOI: 10.1007/s10620-009-0974-2

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  56 in total

1.  Open label trial of granulocyte apheresis suggests therapeutic efficacy in chronically active steroid refractory ulcerative colitis.

Authors:  Wolfgang Kruis; Axel Dignass; Elisabeth Steinhagen-Thiessen; Julia Morgenstern; Joachim Mössner; Stephan Schreiber; Maurizio Vecchi; Alberto Malesci; Max Reinshagen; Robert Löfberg
Journal:  World J Gastroenterol       Date:  2005-11-28       Impact factor: 5.742

Review 2.  Inflammatory bowel disease: clinical aspects and established and evolving therapies.

Authors:  Daniel C Baumgart; William J Sandborn
Journal:  Lancet       Date:  2007-05-12       Impact factor: 79.321

Review 3.  Inflammatory bowel disease: cause and immunobiology.

Authors:  Daniel C Baumgart; Simon R Carding
Journal:  Lancet       Date:  2007-05-12       Impact factor: 79.321

4.  Relationship between fecal calprotectin, intestinal inflammation, and peripheral blood neutrophils in patients with active ulcerative colitis.

Authors:  Hiroyuki Hanai; Ken Takeuchi; Takayuki Iida; Nobuhito Kashiwagi; Abby R Saniabadi; Isao Matsushita; Yoshihiko Sato; Naoki Kasuga; Toshihiro Nakamura
Journal:  Dig Dis Sci       Date:  2004-09       Impact factor: 3.199

Review 5.  C and CX3C chemokines: cell sources and physiopathological implications.

Authors:  Laura Stievano; Erich Piovan; Alberto Amadori
Journal:  Crit Rev Immunol       Date:  2004       Impact factor: 2.214

Review 6.  Monocyte subpopulations and their differentiation patterns during infection.

Authors:  Dalit Strauss-Ayali; Sean M Conrad; David M Mosser
Journal:  J Leukoc Biol       Date:  2007-05-02       Impact factor: 4.962

7.  Selective white cell apheresis reduces relapse rates in patients with IBD at significant risk of clinical relapse.

Authors:  Laurence Maiden; Ken Takeuchi; Rosie Baur; Ingi Bjarnason; John O'Donohue; Ian Forgacs; Guy Chung-Faye; Jeremy Sanderson; Ingvar Bjarnason
Journal:  Inflamm Bowel Dis       Date:  2008-10       Impact factor: 5.325

8.  Selective granulocyte and monocyte adsorptive apheresis as a first-line treatment for steroid naïve patients with active ulcerative colitis: a prospective uncontrolled study.

Authors:  Yasuo Suzuki; Naoki Yoshimura; Abby R Saniabadi; Yasushi Saito
Journal:  Dig Dis Sci       Date:  2004-04       Impact factor: 3.199

9.  Monocyte emigration from bone marrow during bacterial infection requires signals mediated by chemokine receptor CCR2.

Authors:  Natalya V Serbina; Eric G Pamer
Journal:  Nat Immunol       Date:  2006-02-05       Impact factor: 25.606

10.  Immunomodulatory effects of granulocyte and monocyte adsorption apheresis as a treatment for patients with ulcerative colitis.

Authors:  Nobuhito Kashiwagi; Kazuhito Sugimura; Hirobumi Koiwai; Hironori Yamamoto; Toshikazu Yoshikawa; Abby R Saniabadi; Masakazu Adachi; Takashi Shimoyama
Journal:  Dig Dis Sci       Date:  2002-06       Impact factor: 3.199

View more
  3 in total

1.  Expansion of a subset of CD14highCD16negCCR2low/neg monocytes functionally similar to myeloid-derived suppressor cells during SIV and HIV infection.

Authors:  Lucio Gama; Erin N Shirk; Julia N Russell; Karina I Carvalho; Ming Li; Suzanne E Queen; Jorge Kalil; M Christine Zink; Janice E Clements; Esper G Kallas
Journal:  J Leukoc Biol       Date:  2012-02-24       Impact factor: 4.962

Review 2.  Selective granulocyte and monocyte apheresis in inflammatory bowel disease: Its past, present and future.

Authors:  Xiu-Li Chen; Jing-Wei Mao; Ying-De Wang
Journal:  World J Gastrointest Pathophysiol       Date:  2020-05-12

3.  Fecal calprotectin is a useful biomarker for predicting the clinical outcome of granulocyte and monocyte adsorptive apheresis in ulcerative colitis patients: a prospective observation study.

Authors:  Nobuhiro Ueno; Yuya Sugiyama; Yu Kobayashi; Yuki Murakami; Takuya Iwama; Takahiro Sasaki; Takehito Kunogi; Keitaro Takahashi; Kazuyuki Tanaka; Katsuyoshi Ando; Shin Kashima; Yuhei Inaba; Kentaro Moriichi; Hiroki Tanabe; Masaki Taruishi; Yusuke Saitoh; Toshikatsu Okumura; Mikihiro Fujiya
Journal:  BMC Gastroenterol       Date:  2021-08-06       Impact factor: 3.067

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.